Practical considerations for chimeric antigen receptor design and delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Practical considerations for chimeric antigen receptor design and delivery

Published:2017-06-16 Issue:8 Volume:17 Page:961-978
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Oldham Robyn A. A.¹²,Medin Jeffrey A.¹²³⁴

Affiliation:

1. Department of Pediatrics, The Medical College of Wisconsin, Milwaukee, USA

2. Department of Medical Biophysics, University of Toronto, Toronto, Canada

3. Department of Biochemistry, The Medical College of Wisconsin, Milwaukee, USA

4. The Institute of Medical Sciences, University of Toronto, Toronto, Canada

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2017.1339687

Reference269 articles.

1. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

2. The pre-T cell receptor (TCR) complex is functionally coupled to the TCR-zeta subunit.

3. Mechanisms for Regulating Expression of Membrane Isoforms of FcγRIII (CD16)

4. Antigen receptor tail clue

5. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases;Medical Oncology;2024-04-24

2. Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies;Life Sciences;2024-02

3. Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO);Allergy;2021-01

4. Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity;Cancer Immunology Research;2020-10-02

5. Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia;Molecular Therapy - Oncolytics;2020-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3